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Sacral Chondroblastic Osteosarcoma Misdiagnosed as
Chondrosarcoma and Chordoma
Abstract: Chondroblastic osteosarcoma (COS), a subgroup of intramedullary osteosarcoma, is usually located
in the knee region of the body. It is most common in adolescents and early adulthood. COS has similar clinical
and radiological features to those of conventional osteosarcomas.
A 17-year-old male suffered from walking problems and lower limb pain. CT and MRI revealed a mass with
soft tissue density and bone destruction at the level of L5-S1. It was described as “posttraumatic hematoma”.
In cytopathologic examination, initial diagnosis was chordoma in fine-needle aspiration cytology (FNAC),
chondrosarcoma in incisional biopsy, and finally COS in total resection specimen.
Because sacral location of COS is very rare, this report aimed to discuss radiological and pathological diagnostic
pitfalls of COS in light of the literature.
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Kondrosarkom ve Kordoma ile Kar›ﬂt›r›lan Sakral Kondroblastik Osteosarkom
Özet: Kondroblastik osteosarkoma(COS), intramedüller osteosarkom’un bir alt grubudur ve genelde diz
bölgesinde yerleﬂir. Ergenlik ça¤›nda s›kt›r. COS’un klinik ve radyolojik bulgular› di¤er osteosarkomlara benzer.
Yürüme problemleri ve alt ekstremitede a¤r› yak›nmas› olan 17 yaﬂ›nda bir hastan›n tomografi ve MR
incelemelerinde L5-S1 düzeyinde yumuﬂak doku dansitesinde ve kemikte destrüksiyona yol açan kitle saptand›.
Kitle ‘posttravmatik hematom’ olarak rapor edildi. ‹nce i¤ne aspirasyon biyopsisi(FNAC) kordoma, insizyonel
biyopsisi kondrosarkoma olarak rapor edildi ve sonuçta COS total olarak ç›kar›ld›.
Anahtar Sözcükler: Konroblastik Osteosarkom, Kondrosarkom, kordoma, Sakrum

Introduction
Chondroblastic osteosarcoma (COS) is a subgroup of intramedullary osteosarcoma,
and primarily involves the femur and tibia. It is most common in adolescents and in early
adulthood and constitutes 9-25% of osteosarcomas. COSs show similar clinical and
radiological features to those of conventional osteosarcomas. Morphologically, they are
characterized with chondroid and osteoid differentiation (1-3).
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Chondrosarcoma (CS) is the third most frequent bone tumor (20-30%) following
myelomas and osteosarcomas, respectively. They mostly occur in elderly patients with a
peak incidence in the sixth decade. Shoulder, pelvis, proximal femur and costal
involvement are frequently seen, but sacral involvement is very rare (2%) (4).
Chondroid chordomas (CC) are rare malignant tumors that are frequently located in
the sphenooccipital region and predominantly seen in early adulthood and males. They
arise from embryological notochord remnants. They are considered a subgroup of classic
chordomas because of their clinical and pathological differences from classic chordomas
(5-8).
These three neoplasms show chondroid differentiation. Therefore, in small biopsy
specimens, differential diagnosis is difficult. Morphologically accurate diagnosis is
mandatory because of different treatment and clinical features of these three malignant
neoplasms. In this report, problems and solutions related to these three different
entities are discussed.
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Case Report
A 17-year-old male patient with walking problems
and complaints of lower limb pain was admitted to the
Neurosurgery Department of Firat University, Firat
Medical Center. Computed tomography (CT) showed a
mass lesion with soft tissue density and bone destruction
at the level of L5-S1, indicating a posttraumatic
hematoma. Magnetic resonance imaging (MRI) findings
included an enhancing inflammatory soft tissue mass that
compressed on the nerve roots at the level of L5-S2 with
bone destruction. The mass was extending into the spinal
canal and involved S1 and S2 vertebral bodies (Figure 1).
In CT-guided fine-needle aspiration cytology (FNAC)
of this lesion, small multinucleolar, pleomorphic,
transparent malignant tumoral cells with oval-round
nucleus or fusiform large nucleus in myxomatous
background
were
observed
(Figure
2).
Immunohistochemical staining for S-100 (Lab Vision
Corporation, CA, USA) and vimentin (Lab Vision
Corporation, CA, USA) were positive. In FNAC, chordoma
was diagnosed.
In microscopic examination of the biopsy specimen,
lobulated chondroid areas and neoplastic cells were seen
in myxoid background. In cartilaginous areas, there were

Figure 1. MRI shows soft tissue lesion inflicting vertebral destruction
in the presacral region (L5-S2).

Figure 2. FNAC: Neoplastic cells show nuclear membrane irregularity, coarse chromatin, pleomorphism
and hyperchromasia (MGG, x1000).
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neoplastic chondrocytes, some with large nucleus and
coarse chromatin and some with one or more nucleolus
and irregular-edged fine chromatin within lacunae which
were surrounded by hyaline matrix. Cytoplasms of the
neoplastic chondrocytes were narrow with clear
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perinuclear halo (Figure 3). Malignant cells were present
with evident pleomorphism and hyperchromatic nucleus
and without a characteristic pattern within large myxoid
areas around chondroid areas (Figure 4). Based on these
findings, the diagnosis was CS (grade I-II).

Figure 3. Malignant chondroid cells and coagulation necrosis (H&E, x400).

Figure 4. Malignant mesenchymal cells with hyperchromatic and pleomorphic nuclei in myxoid
background (H&E, x200).
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The tumor was totally resected. The specimen
consisted of two pieces (8x6x3 cm and 7x5x2 cm) that
contained bone and soft tissue components. In
microscopic examination, there were lobulated malignant
chondroid areas and oval-spindle shaped malignant cells
in myxoid background. Osteoid formation was located
between spindle malignant cells. Enchondral ossification
was shown in chondroid areas. The tumor was diagnosed
as grade III COS.
In immunohistochemical stain, neoplastic cells were
positive for cytokeratin (Lab Vision Corporation, CA,
USA), epithelial membrane antigen (EMA) (Lab Vision
Corporation, CA, USA) and S-100 (Lab Vision
Corporation, CA, USA). For this reason, initial biopsy
specimens were reassessed. Serial cutting was done of
the small biopsy material and the material on the slide
was larger than of the first slides. There were small
osteoid focuses (Figure 5) and large enchondral
ossification areas. It was concluded that the first biopsy
had been misdiagnosed as CS.
The patient received radiotherapy. No local recurrence
or metastasis was detected in the postoperative 25th
month.

Discussion
CSs are the third most frequent bone tumors with a
predilection for male gender. Peak incidence is in the sixth
decade. The shoulder, pelvis, proximal femur, and costae
are the most frequent sites of involvement. Sacral
involvement (2%) is highly rare (4).
Conventional CSs may be hyalinized, myxoid or mixed.
Hyaline CSs are characterized with hypercellular hyaline
cartilage with atypical chondrocytes within lacunae.
Conversely, in myxoid CSs, atypical chondrocytes are not
seen in the lacunae and constitute large neoplastic cell
groups in myxoid matrix. Neoplastic cells are
immunohistochemically positive for vimentin and S-100
and negative for epithelial markers such as keratin and
EMA in CSs. Generally, typical CS diagnosis can be based
on these findings, but myxoid variant can be confused
with chordoma (4,6).
Chordomas have three subtypes: classical,
dedifferentiated, and chondroid. Unlike conventional
chordoma, CC involves the sphenooccipital region, and it
is more frequent in early adulthood with a better
prognosis (5,6). Conventional chordomas include large
epithelioid cell cords within vesicular myxoid stroma and

Figure 5. Osteoid production (H&E, x400).
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solid nests. Chondroid variant differs from typical
chordoma with its hyalinized stroma and might be
confused with CS. Differential diagnosis of CS and CC is
difficult (7,8). In myxoid CS, neoplastic chondrocytes are
relatively small and narrow. They do not show nest
formation. Conversely, chordoma cells are larger and
have dense eosinophilic cytoplasms. They form groups,
and desmosomes can be seen between cells.
Immunohistochemical staining is very important in
differential diagnosis of these two tumors. Chordomas
are immunohistochemically positive for vimentin, S-100,
EMA and cytokeratin (9,10).
Clinical behavior, recurrence, and metastatic
characteristics of CS and CC are very different.
Therefore, differential diagnosis based on pathological
evaluation is necessary. Theoretically, it is possible to
differentiate CC from classic CS with morphology, but in
practice, it is difficult. Thus, false diagnosis is possible. In
a study with 200 skull base CS, 34% of the cases were
diagnosed as chordoma initially; however, further
morphologic and immunohistochemical assessments
showed that these were actually CS (6).
COS and conventional osteosarcoma have similar
clinical, radiological, and prognostic features. COSs
constitute 9-25% of conventional osteosarcomas (2).
COS can be confused with CS in small biopsy specimens,
and differential diagnosis can be difficult. Differential
diagnosis is necessary because of clinical and treatment
differences between these two neoplasms. Clinical
characteristics such as age and location and radiological
findings help in differentiation of these two neoplasms.
Osteoid formation within the tumor is the most
important morphologic diagnostic feature. It is not
always possible to obtain osteoid formation in small
biopsy specimens. As a consequence, cases with COS
might be misdiagnosed as CS. False diagnosis rate has
been reported to be as high as 44% (3).
Clinical and radiological findings must be used for
differential diagnosis of COS and CS (Table 1). The most
important clinical findings are patient’s age and location
of the lesion. As in our case, the radiological differential
diagnosis of an atypically located lesion might be
impossible. Unni (2) emphasized that in an adolescent
patient or a patient in his/her early adulthood, if the
tumor morphologically constitutes a neoplastic cartilage
and osteoid formation does not accompany, unless
proven to the contrary, it must be considered and treated
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as COS. CS is predominantly seen in the elderly (4th-6th
decade) and is highly rare in adolescents and early
adulthood. Prognosis in CS is better and metastatic
tendency is lower (4).
Our case was initially reported as chordoma based on
the cytology. Further evaluation of biopsy specimen
indicated CS, while the final evaluation of the specimen
showed COS. Therefore, the following points should be
considered throughout the diagnostic process:
1. For accurate diagnosis of bone tumors, clinical
findings such as the age of the patient and location
of the lesion as well as the radiologic findings
should be taken into consideration. Misdiagnosis is
unavoidable if diagnosis is based on morphological
findings alone (1). In our patient, we attempted to
diagnose in view of the morphological findings
alone, not along with clinical and radiological
findings. Pathologists sometimes experience this
kind of important problem, which may be called
“morphology fanaticism” or “morphology
captivity”. Morphology captivity originates from
the idea that only morphological findings are
sufficient for the answers to problems without
any contribution by other diagnostic findings.
Although morphology is important in diagnosis in
certain cases, it is necessary to base the diagnosis
on other findings as well, which is also true for
diagnoses of bone tumors.
2. The patient’s age is a significant parameter for
accurate diagnosis. Our patient was 17 years old.
According to Unni (4), tumors with chondroid
differentiation and without any osteoid formation
in teenage patients must be diagnosed as
osteosarcoma, unless proven to the contrary.
3. Another finding that cytologically supports
chordoma is the location of the tumor because
chordoma is the most frequent neoplasm that
originates from the sacrum. In addition, the
presence of neoplastic cells with vacuolized
cytoplasms, which are like physaliphorous tumor
cells, is supportive of a chordoma. Although
physaliphorous cells are specific for chordoma,
this finding is not diagnostic because these cells
may also be seen in myxomatous tumors (myxoid
CS) (10). However, for myxoid CS and chordoma,
cytological diagnosis cannot be established
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Table 1. Basic features of CC, CS and COS and comparison with our case.

CC

CS

COS

OUR CASE

Age

Early adulthood

Adult - elderly

Adolescent - teenage

17

Location

Sphenooccipital

Pelvis and shoulder (48%)
Sacral 2%

Femur and tibia (67%)
Sacral <1%

Sacral

M/F

2.3/1

1.2/1

1.5/1

M

Clinical findings

Pain, compression
symptoms

Swallowing, pain,
pathologic fracture

Swallowing, pain,
pathologic fracture

Pain, walking
disorder

Radiology

Irregular bone
destruction

Cortical erosion
or thickening
Bone expansion
Calcification

Metaphyseal
radiolucent mass
Spurs, extension to
soft tissue, Codman
triangle, calcification

Hematoma?
Soft tissue infection?

Macroscopy

Lobulated, myxoid mass
Cartilage appearance

Lobulated chondroid
Myxoid changes ±

Cortical penetration
Periost reaction
Extension to soft tissue
Pseudocapsulated

Curetted biopsy
material

Microscopy

Cartilage lobules
Fibrous septa
Hard groups,
cordon or nest forming
epithelial cells,
Desmosome-like
intercellular connections,
Physaliphorous cells

Cell with small and
narrow cytoplasm
No cohesive groups,
cells surrounded
by matrix,
mineralization ±,
ossification ±

Lobulated
chondrosarcomatous
tumor
Osteoid formation
Necrosis, giant cell ±

Lobulated malignant
chondroid areas,
Oval-spindle shaped
malignant cell in
myxoid background
Enchondral
ossification
Osteoid formation

IHC

CK, EMA, Vim, S100 and
5-nucleotidase (+)

S100, Vim (+),
CK, EMA (-)

S100, Vim (+),
Rarely CK, EMA (+)

S100, CK,
EMA (+)

Treatment

Surgery +
Radiotherapy

Surgery +
Radiotherapy

Chemotherapy +
Surgery

Surgery +
Radiotherapy

Distant metastasis

22%

0%

Frequent

Absent

Recurrence

70%

1.5-53%

4%

Absent

10-year survey

35-45%

88-98%

75%

-

COS: Chondroblastic osteosarcoma. CS: Chondrosarcoma. CC: Chondroid chordoma. IHC: Immunohistochemistry. M: Male. F: Female. CK: Cytokeratin. Vim: Vimentin. EMA: Epithelial membrane antigen.

accurately
assessment.

without

immunohistochemical

4. If clinical, radiological and morphologic findings
are discordant, the lesion should be described and
other possible diagnoses should be kept in mind to
achieve an accurate diagnosis.
5. When diagnosis is made based on small biopsy
specimens, whole tissue in all blocks should be cut
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with serial sections and no result should be
declared without assessment of the entire tissue.
In our case, the blocks cut with serial sections and
their further reassessment showed diagnostic
osteoid areas in two-fold compared to the
previous evaluations of tissue sections, which
supported osteosarcoma.
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